Adverse drug reactions in a pediatric oncology unit of a university hospital

Authors

  • MARCELINO OLIVEIRA CAZÉ
  • BRUNO SIMAS DA ROCHA
  • MAITÊ TELLES DOS SANTOS
  • FERNANDA ROSSATTO MACHADO
  • GABRIELA FUMEGALLI
  • DEISE LUISA LOCATELLI
  • JACQUELINE KOHUT MARTINBIANCHO
  • LAURO JOSE GREGIANIN

Keywords:

Farmacovigilância, Serviço Hospitalar de Oncologia, Pediatria, Efeitos Colaterais e Reações Adversas Relacionadas a Medicamentos, Sistemas de Notificação de Reações Adversas a Medicamentos, Serviço de Farmácia Clínica

Abstract

Objectives: Conduct descriptive analysis of adverse drug reactions (ADRs) occurred in a pediatric oncology unit. Methods: retrospective cross-sectional study of patients admitted to a pediatric oncology unit in June 2014 to May 2015. Reactions were identified by active search in medical records and reports from the medical and nursing staff. ADRs were classified as causality of Naranjo algorithm, predictability, and severity. Data were tabulated and codified in SPSS software for analysis. Results: 87 ADRs were reported. The mean age of patients presenting reactions was 9.57 years and the average number of medications in the prescription was 17.47. Antimicrobials were the drug class with most reports, 19 (21.84%) of the cases. The skin was the site where the greatest number of reactions occurred, 46 (52.9%) of occasions. The ADR was considered severe in 26.4% of cases (antineoplastics being the drug class more related with this severity) and moderate in 61.6 % of cases. The reaction was classified as probable in 56 (64.4%) of occasions and predictability was considered as type A in 63 (82.4%) of the events. Conclusion: the reactions occurred more frequently with the use of antimicrobial, antifungal and antineoplastic drugs. Most of the events had cutaneous manifestations and were moderate, allowing easier recognition and less complex management by the multidisciplinary team. The clinical pharmacist assumed an important role in the prevention, detection, reporting and monitoring of ADRs in pediatric oncology, becoming responsible for actions that promote safe use of medicines. 

Downloads

Download data is not yet available.

Downloads

Published

2019-03-11

How to Cite

1.
CAZÉ MO, ROCHA BSD, SANTOS MTD, MACHADO FR, FUMEGALLI G, LOCATELLI DL, MARTINBIANCHO JK, GREGIANIN LJ. Adverse drug reactions in a pediatric oncology unit of a university hospital. Rev Bras Farm Hosp Serv Saude [Internet]. 2019Mar.11 [cited 2024Jul.16];6(3). Available from: https://rbfhss.org.br/sbrafh/article/view/226

Issue

Vol. 6 No. 3 (2015): Jul-Sep

Section

ARTIGOS PUBLICADOS

License

The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

 

Serlf-archiving policy

This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.